Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2026-05-29 Declaration of Voting R…
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Thông báo về ngày đăng ký cuối cùng tổ chức lấy ý kiến cổ đông bằng văn bản năm 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is an official notice from the Ho Chi Minh City Stock Exchange regarding the record date (‘ngày đăng ký cuối cùng’) for the upcoming shareholders’ written vote in 2026. It sets out ex‐rights date, record date, purpose of taking shareholder written consent, vote ratio, and timing/location – all details typical of a Voting Rights Announcement. Therefore, it falls under “Declaration of Voting Results & Voting Rights Announcements” (DVA), specifically a Voting Rights Announcement.
2026-05-29 Vietnamese
IMP: Thông báo về ngày đăng ký cuối cùng để thực hiện quyền lấy ý kiến cổ đông bằng văn bản năm 2026
Regulatory Filings Classification · 85% confidence The document is an irregular, non-periodic announcement by Imexpharm to the State Securities Commission and Ho Chi Minh Stock Exchange notifying the record date for exercising shareholders’ written voting rights. It contains no financial statements, results, or detailed proxy materials—just a compliance notification of a corporate action record date. This falls under general regulatory announcements that don’t fit other categories.
2026-05-26 Vietnamese
IMP: Thông báo đề cử, ứng cử thành viên HĐQT nhiệm kỳ 2023-2027
Board/Management Information Classification · 90% confidence The document is an official notice from Imexpharm Corporation regarding the nomination and self-nomination of candidates for election as replacement members of the Board of Directors for the remainder of the 2023–2027 term. It outlines the planned changes in the board composition, the number of seats to be filled, criteria, and submission instructions for dossiers. This clearly pertains to board/management information rather than a financial report or regulatory form, fitting the description of a Board/Management Information filing.
2026-05-26 Vietnamese
IMP: Nghị quyết HĐQT về việc chốt danh sách cổ đông để lấy ý kiến cổ đông bằng văn bản
Board/Management Information Classification · 90% confidence The document is a disclosure of a Board of Directors’ resolution concerning the resignation of existing board members and arrangements for nominating and electing replacements. It is an announcement of changes in the company’s board of directors, matching the Board/Management Information category.
2026-05-26 Vietnamese
IMP: Thông báo nhận được Đơn từ nhiệm các thành viên HĐQT
Board/Management Information Classification · 95% confidence The document is a stock exchange disclosure (CBTT) announcing the receipt of resignation letters from three members of the Board of Directors. It clearly pertains to changes in the company’s board. This fits the definition for Board/Management Information (MANG).
2026-05-19 Vietnamese
IMP: Nghị quyết HĐQT về việc lựa chọn đơn vị kiểm toán BCTC 2026
Regulatory Filings Classification · 75% confidence The document is an announcement/disclosure of a Board resolution selecting an independent audit firm for FY2026. It is filed with the State Securities Commission and stock exchange as a corporate regulatory announcement. It does not contain financial statements or the audit report itself, nor is it a notice of dividend or management change. Hence it falls under general regulatory filings (RNS).
2026-05-15 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.